385 related articles for article (PubMed ID: 9074807)
21. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Draper AJ; Madan A; Parkinson A
Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
[TBL] [Abstract][Full Text] [Related]
22. Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5.
Abu-Bakar A; Moore MR; Lang MA
Biochem Pharmacol; 2005 Nov; 70(10):1527-35. PubMed ID: 16183037
[TBL] [Abstract][Full Text] [Related]
23. Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis.
Kim D; Wu ZL; Guengerich FP
J Biol Chem; 2005 Dec; 280(48):40319-27. PubMed ID: 16207711
[TBL] [Abstract][Full Text] [Related]
24. Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.
Hasler JA; Harlow GR; Szklarz GD; John GH; Kedzie KM; Burnett VL; He YA; Kaminsky LS; Halpert JR
Mol Pharmacol; 1994 Aug; 46(2):338-45. PubMed ID: 8078495
[TBL] [Abstract][Full Text] [Related]
25. Expression of cytochrome P450 2A6 in Escherichia coli: purification, spectral and catalytic characterization, and preparation of polyclonal antibodies.
Soucek P
Arch Biochem Biophys; 1999 Oct; 370(2):190-200. PubMed ID: 10510277
[TBL] [Abstract][Full Text] [Related]
26. Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions.
Lewis DF; Lake BG
Xenobiotica; 2002 Jul; 32(7):547-61. PubMed ID: 12162851
[TBL] [Abstract][Full Text] [Related]
27. Cytochrome P450 2A13 enhances the sensitivity of human bronchial epithelial cells to aflatoxin B1-induced DNA damage.
Yang X; Zhang Z; Wang X; Wang Y; Zhang X; Lu H; Wang SL
Toxicol Appl Pharmacol; 2013 Jul; 270(2):114-21. PubMed ID: 23602888
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450 2A of nasal epithelium: regulation and role in carcinogen metabolism.
Béréziat JC; Raffalli F; Schmezer P; Frei E; Geneste O; Lang MA
Mol Carcinog; 1995 Oct; 14(2):130-9. PubMed ID: 7576100
[TBL] [Abstract][Full Text] [Related]
29. CYP2A6: a human coumarin 7-hydroxylase.
Pelkonen O; Rautio A; Raunio H; Pasanen M
Toxicology; 2000 Apr; 144(1-3):139-47. PubMed ID: 10781881
[TBL] [Abstract][Full Text] [Related]
30. Cytochrome P450 2A13 mediates the neoplastic transformation of human bronchial epithelial cells at a low concentration of aflatoxin B1.
Zhang Z; Lu H; Huan F; Meghan C; Yang X; Wang Y; Wang X; Wang X; Wang SL
Int J Cancer; 2014 Apr; 134(7):1539-48. PubMed ID: 24114584
[TBL] [Abstract][Full Text] [Related]
31. Molecular cloning and expression of a novel cytochrome p450 from turkey liver with aflatoxin b1 oxidizing activity.
Yip SS; Coulombe RA
Chem Res Toxicol; 2006 Jan; 19(1):30-7. PubMed ID: 16411653
[TBL] [Abstract][Full Text] [Related]
32. Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity.
Lewis DF; Dickins M; Lake BG; Eddershaw PJ; Tarbit MH; Goldfarb PS
Toxicology; 1999 Mar; 133(1):1-33. PubMed ID: 10413191
[TBL] [Abstract][Full Text] [Related]
33. Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer.
Guengerich FP; Johnson WW; Ueng YF; Yamazaki H; Shimada T
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):557-62. PubMed ID: 8781383
[TBL] [Abstract][Full Text] [Related]
34. Altering the regiospecificity of androstenedione hydroxylase activity in P450s 2a-4/5 by a mutation of the residue at position 481.
Iwasaki M; Darden TA; Pedersen LG; Negishi M
Biochemistry; 1995 Apr; 34(15):5054-9. PubMed ID: 7711025
[TBL] [Abstract][Full Text] [Related]
35. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
Spracklin DK; Thummel KE; Kharasch ED
Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
[TBL] [Abstract][Full Text] [Related]
36. Metabolic interactions of methoxsalen and coumarin in humans and mice.
Mäenpää J; Juvonen R; Raunio H; Rautio A; Pelkonen O
Biochem Pharmacol; 1994 Oct; 48(7):1363-9. PubMed ID: 7945434
[TBL] [Abstract][Full Text] [Related]
37. Genotoxicity of aflatoxin B1: evidence for a recombination-mediated mechanism in Saccharomyces cerevisiae.
Sengstag C; Weibel B; Fasullo M
Cancer Res; 1996 Dec; 56(23):5457-65. PubMed ID: 8968101
[TBL] [Abstract][Full Text] [Related]
38. Structural function of residue-209 in coumarin 7-hydroxylase (P450coh). Enzyme-kinetic studies and site-directed mutagenesis.
Juvonen RO; Iwasaki M; Negishi M
J Biol Chem; 1991 Sep; 266(25):16431-5. PubMed ID: 1885576
[TBL] [Abstract][Full Text] [Related]
39. Evidence for metabolic activation of N'-nitrosonornicotine and N-nitrosobenzylmethylamine by a rat nasal coumarin hydroxylase.
Patten CJ; Peterson LA; Murphy SE
Drug Metab Dispos; 1998 Feb; 26(2):177-80. PubMed ID: 9456305
[TBL] [Abstract][Full Text] [Related]
40. Toxicity of aflatoxin B1 to Helicoverpa zea and bioactivation by cytochrome P450 monooxygenases.
Zeng RS; Niu G; Wen Z; Schuler MA; Berenbaum MR
J Chem Ecol; 2006 Jul; 32(7):1459-71. PubMed ID: 16830213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
